Sleep Apnea News and Research

RSS

CPAP therapy lowers depressive symptoms in people with obstructive sleep apnea

A new study shows that depressive symptoms are extremely common in people who have obstructive sleep apnea, and these symptoms improve significantly when sleep apnea is treated with continuous positive airway pressure therapy.

23 Sep 2015

Brain health: how can you reduce cognitive decline? An interview with Heather Snyder, Ph.D.

Reader’s Digest and the Alzheimer’s Association partnered to survey approximately 1,600 people in May 2015 about their brain health and their knowledge of how lifestyle habits affect cognitive decline and dementia.

22 Sep 2015

World expert panel recommends routine brain health screening for adults older than 70

A panel of world experts in aging convened at Saint Louis University recommended that everyone 70 and older should have their memory and reasoning ability evaluated annually by a doctor or health care provider.

10 Sep 2015

Latest ENT research to be presented at AAO-HNSF's annual meeting

The latest research on hearing loss, head and neck cancers, sleep apnea and other otolaryngic topics will be presented in Dallas, TX, September 27-30, at the 2015 Annual Meeting & OTO EXPO? of the American Academy of Otolaryngology--Head and Neck Surgery Foundation (AAO-HNSF), the largest annual meeting of ear, nose, throat, head and neck physicians in the world.

9 Sep 2015

Simple test can lead to early detection of sleep apnea in hospitalized heart failure patients

Researchers at Thomas Jefferson University showed that a simple questionnaire, evaluation and pulse-oximetry monitoring can lead to early detection of sleep apnea in patients hospitalized for congestive heart failure (CHF).

9 Sep 2015

14th APS symposium highlights role of endothelin in many biological functions

Endothelin (ET) is a peptide produced by cells in the blood vessels and has powerful vessel-constricting effects. Although endothelin is mainly associated with its role in blood pressure control and cardiovascular diseases, it continues to appear in other physiological functions and diseases.

4 Sep 2015

Bedwetting symptom may help identify OSA in post-menopausal women

The results of a new study suggest that nocturnal enuresis, or bedwetting, may be an additional symptom that doctors can look for when assessing post-menopausal women for obstructive sleep apnea. That condition left untreated can lead to serious medical problems, such as cardiovascular disease, as organs are undersupplied with oxygen.

3 Sep 2015

CPAP treatment restores brain stem function, reverses health changes linked to heart disease

Continuous positive airway pressure (CPAP) machines are a commonly prescribed treatment for obstructive sleep apnea, a disorder in which muscles in the airways collapse during sleep, blocking breathing.

2 Sep 2015

UT Arlington, UNTHSC researchers develop user-friendly system alerts for people with sleep apnea

Masks worn by those with sleep apnea can leak at night and be so uncomfortable that they often drive users away from treatment. But a new system being developed by researchers at UNT Health Science Center and The University of Texas at Arlington could make it easier for the estimated 18 million people with sleep apnea to get a good night's rest.

14 Aug 2015

Women's Medicine Collaborative awarded NIH grant to study link between placenta and sleep abnormalities

The National Institutes of Health has awarded $2.7 million to the Women's Medicine Collaborative to study the placenta and its function to determine whether changes in the placenta are linked to sleep abnormalities.

14 Aug 2015

John T. Spitznagel attains recognition in Strathmore's Who's Who for contributions in Healthcare Sales and Marketing

John T. Spitznagel of Glen Burnie, Maryland, has attained recognition in Strathmore's Who's Who for his contributions and achievements in the field of Healthcare Sales and Marketing. On Friday, July 31, 2015, he will be honored with a Times Square, New York appearance.

31 Jul 2015

inSleep Health receives FDA clearance for Cloud9 Anti-Snoring System

inSleep Health announced today that it has received 510(K) clearance for the company's Cloud9 Anti-Snoring System. The indication for use is to reduce or eliminate simple snoring in adults. Cloud9 is a prescription device for home use. This is the first clinically proven device, using continuous low positive airway pressure, specifically labeled to treat simple snoring.

29 Jul 2015

Changes in body temperature can cause sudden cardiac death, finds SFU research

Scientists, including SFU professor Peter Ruben, have found that sudden death caused by cardiac arrhythmia can be triggered by changes in body temperature. The study is published in the Journal of Physiology.

17 Jul 2015

Researchers create clinical pathway to identify OSA in high-risk, hospitalized patients

Obstructive Sleep Apnea (OSA) remains under-recognized in hospitalized patients, despite being associated with cardiovascular complications and sudden death. A multi-disciplinary group of researchers and physicians at Thomas Jefferson University and Hospitals have created a clinical pathway, or screening process, to identify the disorder in higher-risk, hospitalized patients and recently published the results in the Journal of Clinical Sleep Medicine.

16 Jul 2015

American Thoracic Society releases recommendations on achieving good quality sleep

The American Thoracic Society has released a policy statement with recommendations for clinicians and the general public on achieving good quality sleep and getting an adequate quantity of sleep.

15 Jun 2015

New web-based community portal aims to improve diagnosis and treatment for sleep apnea

A new web-based community portal, http://www.MyApnea.Org, is recruiting patients, caregivers and those at risk for sleep apnea to join a growing community of patients and researchers to better understand sleep apnea through information sharing, support and research.

11 Jun 2015

Jazz enrolls first patients in JZP-110 Phase 3 study for treatment of EDS in patients with narcolepsy or OSA

Jazz Pharmaceuticals plc announced today that the first patients have been enrolled in a Phase 3 clinical development program evaluating the safety and efficacy of its investigational drug candidate, JZP-110, as a wake-promoting agent in the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy or with obstructive sleep apnea (OSA).

8 Jun 2015

Eating less late at night may help reduce effects of sleep deprivation

Eating less late at night may help curb the concentration and alertness deficits that accompany sleep deprivation, according to results of a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania that will be presented at SLEEP 2015, the 29th annual meeting of the Associated Professional Sleep Societies LLC.

5 Jun 2015

Key lifestyle changes could help reduce risk of cognitive decline

The evidence is mounting: People can reduce their risk of cognitive decline by making key lifestyle changes. That is the conclusion of a new research summary published online today in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

1 Jun 2015

TSRI scientists awarded $2.2 million NIH grant to advance innovative approach to obesity treatment

Scientists from the Florida campus of The Scripps Research Institute have been awarded nearly $2.2 million by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to advance an innovative approach to the treatment of obesity, a serious health problem that affects more than one-third of all Americans.

28 May 2015